A J Cmelak

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi Radiosurgery for skull base malignancies and nasopharyngeal carcinoma
    A J Cmelak
    Department of Radiation Oncology, Stanford University Medical Center, CA, USA
    Int J Radiat Oncol Biol Phys 37:997-1003. 1997
  2. ncbi Low-dose stereotactic radiosurgery is inadequate for medically intractable mesial temporal lobe epilepsy: a case report
    A J Cmelak
    Department of Radiation Oncology, Vanderbilt Medical Center, Nashville, TN 37232, USA
    Seizure 10:442-6. 2001
  3. doi A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02)
    R E Drzymala
    Department of Radiation Oncology, Washington University Medical Center, St Louis, MO 63110, USA
    Radiother Oncol 87:89-92. 2008
  4. ncbi Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer
    A J Cmelak
    Department of Radiation Oncology, Stanford University School of Medicine, California 94305, USA
    Gynecol Oncol 65:453-60. 1997
  5. pmc Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study
    M A Deeley
    Department of Radiation Oncology, Vanderbilt University, Nashville, TN, USA
    Phys Med Biol 56:4557-77. 2011

Detail Information

Publications5

  1. ncbi Radiosurgery for skull base malignancies and nasopharyngeal carcinoma
    A J Cmelak
    Department of Radiation Oncology, Stanford University Medical Center, CA, USA
    Int J Radiat Oncol Biol Phys 37:997-1003. 1997
    ..In 1989 we began treating selected patients with skull base lesions using linac stereotactic radiosurgery. In this study the efficacy and toxicity of this therapeutic modality is investigated...
  2. ncbi Low-dose stereotactic radiosurgery is inadequate for medically intractable mesial temporal lobe epilepsy: a case report
    A J Cmelak
    Department of Radiation Oncology, Vanderbilt Medical Center, Nashville, TN 37232, USA
    Seizure 10:442-6. 2001
    ..The toxicity and efficacy of higher-dose radiosurgery is currently under investigation...
  3. doi A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02)
    R E Drzymala
    Department of Radiation Oncology, Washington University Medical Center, St Louis, MO 63110, USA
    Radiother Oncol 87:89-92. 2008
    ..The toxicity is reported in three groups of patients according to the tumor size. Etanidazole doses of 12g/m2 combined with radiosurgery were well tolerated...
  4. ncbi Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer
    A J Cmelak
    Department of Radiation Oncology, Stanford University School of Medicine, California 94305, USA
    Gynecol Oncol 65:453-60. 1997
    ..With acceptable toxicity, WAI results appear to be as good as or better than second-line chemotherapy, particularly in platinum-refractory patients...
  5. pmc Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study
    M A Deeley
    Department of Radiation Oncology, Vanderbilt University, Nashville, TN, USA
    Phys Med Biol 56:4557-77. 2011
    ..This work underscores the need for large scale studies utilizing statistically robust numbers of patients and experts in evaluating quality of automatic algorithms...